News stories about Smith & Nephew (NYSE:SNN) have been trending somewhat positive this week, Accern reports. Accern scores the sentiment of news coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Smith & Nephew earned a news impact score of 0.15 on Accern’s scale. Accern also gave media headlines about the medical equipment provider an impact score of 45.9617832017327 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

Several equities research analysts have issued reports on the company. Morgan Stanley downgraded Smith & Nephew from an “overweight” rating to an “equal weight” rating in a report on Monday, December 11th. JPMorgan Chase & Co. upgraded Smith & Nephew from a “neutral” rating to an “overweight” rating in a report on Thursday, January 25th. Canaccord Genuity restated a “buy” rating and set a $45.00 price objective on shares of Smith & Nephew in a report on Friday, January 5th. Zacks Investment Research upgraded Smith & Nephew from a “sell” rating to a “hold” rating in a report on Wednesday, February 7th. Finally, ValuEngine downgraded Smith & Nephew from a “buy” rating to a “hold” rating in a report on Friday, February 9th. Three research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. The stock has an average rating of “Buy” and a consensus price target of $44.00.

How to Become a New Pot Stock Millionaire

SNN stock traded up $0.26 during mid-day trading on Wednesday, reaching $37.81. The company’s stock had a trading volume of 688,911 shares, compared to its average volume of 746,018. Smith & Nephew has a 52 week low of $30.73 and a 52 week high of $40.43. The company has a current ratio of 2.03, a quick ratio of 1.06 and a debt-to-equity ratio of 0.31.

The company also recently declared a None dividend, which will be paid on Wednesday, May 9th. Stockholders of record on Friday, April 6th will be issued a $0.444 dividend. The ex-dividend date of this dividend is Thursday, April 5th.

TRADEMARK VIOLATION WARNING: This piece of content was originally posted by Watch List News and is owned by of Watch List News. If you are reading this piece of content on another website, it was copied illegally and republished in violation of international copyright and trademark legislation. The original version of this piece of content can be accessed at https://www.watchlistnews.com/somewhat-positive-news-coverage-somewhat-unlikely-to-affect-smith-nephew-snn-share-price/1954423.html.

Smith & Nephew Company Profile

Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.

Insider Buying and Selling by Quarter for Smith & Nephew (NYSE:SNN)

Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.